文献速递头颈外科

原发性腮腺恶性肿瘤中特定颈部分区淋巴结转移发生率的系统综述与Meta分析

Systematic Review and Meta-Analysis on the Incidence of Level-Specific Cervical Nodal Metastasis in Primary Parotid Malignancies.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-01-29

该系统综述与Meta分析纳入13篇文献共818例原发性腮腺恶性肿瘤患者,采用随机效应模型计算颈部分区淋巴结转移的合并发生率。结果显示,全部颈清扫标本中颈部淋巴结受累总发生率为47%(95%CI 31%-63%),临床淋巴结阳性(cN+)患者为89%(95%CI 75%-98%),临床淋巴结阴性(cN0)患者为32%(95%CI 14%-53%)。作者建议需行颈部择区性治疗的原发性腮腺恶性肿瘤患者行包含II至III区的择区性颈清扫,并根据临床判断纳入IV区;行治疗性颈清扫者应行全颈清扫(I-V区)。

要点

  • 全部颈清扫标本中颈部淋巴结受累总发生率为47%(95%CI 31%-63%)。
  • cN+患者淋巴结阳性发生率为89%(95%CI 75%-98%),cN0患者为32%(95%CI 14%-53%)。
  • cN0患者转移发生率最高为II区(28%)和III区(11%)。

核心结论

  • 原发性腮腺恶性肿瘤中,临床淋巴结阴性颈部的隐匿性转移发生率为32%,而临床淋巴结阳性颈部为89%。

研究设计与样本

  • 系统综述与随机效应Meta分析,纳入13篇文献共818例原发性腮腺恶性肿瘤患者,检索MEDLINE、EMBASE、PubMed和Cochrane数据库。

主要发现

  • 全部颈清扫标本中颈部淋巴结受累总发生率为47%(95%CI 31%-63%)。
  • cN+患者淋巴结阳性发生率为89%(95%CI 75%-98%),cN0患者为32%(95%CI 14%-53%)。
  • cN+患者各分区淋巴结转移发生率均较高:I区33%、II区73%、III区48%、IV区39%、V区37%。
  • cN0患者淋巴结转移发生率最高为II区(28%)和III区(11%)。

关键数值与推荐

  • 作者建议:需行颈部择区性治疗的原发性腮腺恶性肿瘤患者,行包含II至III区的择区性颈清扫,并根据临床判断纳入IV区。
  • 作者建议:行治疗性颈清扫的患者应行全颈清扫(I-V区)。

临床怎么用

  • 作者建议对需行颈部择区性治疗的原发性腮腺恶性肿瘤患者行包含II至III区的择区性颈清扫,并根据临床判断纳入IV区。
  • 作者建议对行治疗性颈清扫的患者行全颈清扫(I-V区)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In primary parotid gland malignancies, the incidence of level-specific cervical lymph node metastasis in clinically node-positive necks remains unclear. This study aimed to determine the incidence of level-specific cervical node metastasis in clinically node-negative (cN0) and node-positive (cN+) patients who presented with primary parotid malignancies. DATA SOURCES: Electronic databases (MEDLINE, EMBASE, PubMed, Cochrane). REVIEW METHODS: Random-effects meta-analysis was used to calculate pooled estimate incidence of level-specific nodal metastasis for parotid malignancies with 95% confidence intervals (CIs). Subgroup analyses of cN0 and cN+ were performed. RESULTS: Thirteen publications consisting of 818 patients were included. The overall incidence of cervical nodal involvement in all neck dissections was 47% (95% CI, 31%-63%). Among those who were cN+, the incidence of nodal positivity was 89% (95% CI, 75%-98%). Those who were cN0 had an incidence of 32% (95% CI, 14%-53%). In cN+ patients, the incidence of nodal metastasis was high at all levels (level I 33%, level II 73%, level III 48%, level IV 39%, and level V 37%). In cN0 patients, the incidence of nodal metastasis was highest at levels II (28%) and III (11%). CONCLUSION: For primary parotid malignancies, the incidence of occult metastases was 32% compared to 89% in a clinically positive neck. It is recommended that individuals with a primary parotid malignancy requiring elective treatment of the neck have a selective neck dissection which involves levels II to III, with the inclusion of level IV based on clinical judgment. Those undergoing a therapeutic neck dissection should undergo a comprehensive neck dissection (levels I-V).

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Ho JPK, Mair M, Noor A, et al. Systematic Review and Meta-Analysis on the Incidence of Level-Specific Cervical Nodal Metastasis in Primary Parotid Malignancies. Otolaryngol Head Neck Surg. 2023. PMID: 36939620. doi:10.1002/ohn.207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。